Our Programmes

We are developing a Drug-Eluting Bead (CellBead Neuro) for the treatment of neurological trauma and neurological degeneration.

The cosmetic dermatology programme (Dermal Bead) in partnership with the pharmaceuticals subsidiary of the Merz Group is focused on the dermal filler market segment.

Glucagon Like Peptide is widely viewed as an important emerging treatment for diabetes and obesity.  CellMed is working with GLP-1 in two different ways.

A Haemoglobin test kit for the testing of the haemoglobin level in human blood which is primarily sold to blood banks and doctors' surgeries.